Interview with Bogdan Bradosche, Finance Minister – Active CEO, Roche SA
South Africa is at the moment one of the world’s most exciting and dynamic markets at the moment as Mr. Omar Ehsan was telling us, the most exciting market he…
Roche Diagnostics has a proud tradition of innovation in healthcare around the globe. We are committed to making a real difference in people’s lives by providing products and services for the diagnosis of diseases. One of our objectives is to develop new diagnostic tools to support healthcare professionals and patients, in their efforts to manage diseases and healthcare costs.
Our leadership in innovation is evident in our Early Infant Diagnosis of HIV program built on our globally renowned Polymerase Chain Reaction (PCR) technology. The introduction of a Dried Blood Spot (DBS) sampling option for this program has had a direct benefit for all stakeholders in the healthcare industry namely, patients, clinicians, administrators and program funders.
Roche Diagnostics’ adoption of innovation within these programs is not limited to the development of in-vitrodiagnostic assays for high burden diseases such as HIV/AIDS and TB, but also encompasses other aspects of process workflow in an effort to create sustainable solutions for the challenges posed within resource-limited regions. This is achieved through the AmpliCare Initiative, which was our proactive response to the need to expand diagnostics to these settings.
We are committed to capacity building initiatives through ongoing certified training of laboratory scientists at the Roche PCR Academy in Johannesburg, to ensure highest results, quality and reliability. This training includes education of Health Care Professionals on molecular theory and techniques enabling them to deliver better patient management outcomes.
Through Roche’s research and development initiatives, we also apply our expertise to develop novel solutions, precise and robust diagnostic tests, automated systems and integrated solutions in the fields of Clinical Chemistry, Hematology, Coagulation and Immunodiagnostics.
We believe that through continued effort and investment in the latest innovations in diagnostics, Roche can make a positive, sustainable and cost-effective contribution to developing world healthcare.
Roche Diagnostics is the world leader in in vitro diagnostics. Roche Diagnostics offers a uniquely broad product portfolio and supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals and laboratories in the fields of diabetes care and anticoagulation therapy, molecular biology, clinical chemistry, immunology and applied science.
Contact Details
Roche Products (Pty) Ltd
9 Will Scarlet Road
P O Box 1927,Randburg
2125, South Africa
South Africa is at the moment one of the world’s most exciting and dynamic markets at the moment as Mr. Omar Ehsan was telling us, the most exciting market he…
Could you introduce to our readers MC Pharma’s business model in the South African market as well as the main milestones in the company’s development over the recent years? MC…
Mr. Daniel, after working with Pfizer Australia, working in Hong Kong as Regional Marketing Director for the Asian operation and in Japan, you have been the first South African appointed…
South Africa has recently achieved the 1st Millennium Development Goal (MDG) – reducing the proportion of the population living on less than 1 USD a day by half – but…
Our international readers know about South Africa’s socio-economic relative achievements, considering the country joined the BRICS grouping last year and achieved the first Millennium Development Goal (MDG) that same year.…
Mr Kahanovitz, Focus Reports came to South Africa in 2005 to produce a similar report on the South African pharmaceutical industry. Could you come back for us on the main…
The story of Novo Nordisk South Africa began in 1959 in Johannesburg. It was among the first affiliates outside of Denmark, with insulin and anti-infectives produced locally. To what extent…
You have worked at Roche for several years as Business unit Manager. Therefore you are familiar with the strategy of the company and the intricacies of the job. The new…
Having spent two months as the head of Novartis South Africa, what is your first assignment as General Manager, could you share with our readers what were the surprises for…
Mr. Miller, you have been Vice President and Managing Director of Mylan’s operations in South Africa since 2008. What mission were you assigned back then, and in those three years,…
South Africa carries one of the world’s most disproportionate disease burdens, the worst of so-called westernised diseases, such as cardiac disease, diabetes etc on the one hand and the developmental…
Ms Joubert, could you start by telling our readers over the 16 months of heading the operations here, what have been the most challenging situations as the General Manager of…
See our Cookie Privacy Policy Here
